Principal Securities’s AbbVie ABBV Stock Holding History

Principal Securities’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.3M	Sell	44,899 -13,618	-23%	-$2.93M	0.14%	144
2026 Q1	$12.7M	Sell	58,517 -6,052	-9%	-$1.34M	0.19%	107
2025 Q4	$14.8M	Buy	64,569 +5,218	+9%	+$1.19M	0.23%	80
2025 Q3	$13.7M	Buy	59,351 +1,480	+3%	+$301K	0.23%	80
2025 Q2	$10.7M	Buy	57,871 +12,131	+27%	+$2.25M	0.2%	98
2025 Q1	$8.13M	Buy	45,740 +50	+0.1%	+$9.72K	0.18%	109
2024 Q4	$8.12M	Buy	45,690 +5,248	+13%	+$965K	0.18%	106
2024 Q3	$7.99M	Buy	40,442 +2,522	+7%	+$471K	0.19%	99
2024 Q2	$6.5M	Buy	37,920 +4,789	+14%	+$793K	0.18%	102
2024 Q1	$6.03M	Buy	33,131 +1,248	+4%	+$215K	0.19%	108
2023 Q4	$4.94M	Buy	+31,883	New	+$4.65M	0.18%	113

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Principal Securities's ABBV Position: Q2 2026 in Review

Principal Securities reduced its AbbVie (ABBV) stake by 23% in Q2 2026, selling an estimated $2.93M and leaving 44,899 shares worth $11.3M. The position accounts for 0.14% of the portfolio, ranked #144.

Principal Securities first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $14.8M in Q4 2025. 4,217 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Principal Securities held 44,899 shares of AbbVie worth $11.3M as of Q2 2026.
Principal Securities sold 13,618 AbbVie shares in Q2 2026, an estimated $2.93M.
AbbVie made up 0.14% of Principal Securities's portfolio in Q2 2026, its #144 holding.
Principal Securities first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
Principal Securities's AbbVie position peaked at $14.8M in Q4 2025.
4,217 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Principal Securities's 13F filing for Q2 2026, filed 4 Aug 2026.